Inventor · disambiguated record
Michael J. Yellin
Also filed as: YELLIN MICHAEL J · YELLIN Michael
13 granted patents·9 pending applications·481 citations·filing 1991–2019
95Inventor score
Top patents by PatentIndex Score
22 records- 0197US5474771AMurine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing sameUNIV COLUMBIA·Filed 1991·Granted Dec 12, 1995·152 cites·14 claims
- 0293US6793924B2Protein recognized by an antibody that specifically binds an epitope that is specifically bound by monoclonal antibody 5c8.UNIV COLUMBIA·Filed 2002·Granted Sep 21, 2004·31 cites·6 claims
- 0388US7611702B2TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapyMEDAREX INC·Filed 2006·Granted Nov 3, 2009·12 cites·20 claims
- 0488US6610294B1Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 bindsUNIV COLUMBIA·Filed 1992·Granted Aug 26, 2003·36 cites·16 claims
- 0588US6403091B1Methods for inhibiting the rejection of a transplant organ in a subject with 5C8-specific antibodiesUNIV COLUMBIA·Filed 1995·Granted Jun 11, 2002·42 cites·13 claims
- 0687US6451310B1Method for inhibiting an allergic response with a 5c8-specific antibodyUNIV COLUMBIA·Filed 1995·Granted Sep 17, 2002·41 cites·15 claims
- 0785US6455044B15c8 antigenUNIV COLUMBIA·Filed 1999·Granted Sep 24, 2002·33 cites·5 claims
- 0884US6592868B1Methods for treating autoimmune diseases with 5C8-specific antibodiesUNIV COLUMBIA·Filed 1995·Granted Jul 15, 2003·33 cites·18 claims
- 0982US6340459B1Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipientsUNIV COLUMBIA·Filed 1996·Granted Jan 22, 2002·53 cites·23 claims
- 1066US6331433B1Human T cell leukemia cell line designated D1.1UNIV COLUMBIA·Filed 1999·Granted Dec 18, 2001·10 cites·4 claims
- 1166US6331615B1Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)UNIV COLUMBIA·Filed 1999·Granted Dec 18, 2001·10 cites·12 claims
- 1266US5993816AMethods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodiesTRUSTEES OF COLUMBIA UNVERSITY·Filed 1995·Granted Nov 30, 1999·13 cites·14 claims
- 1362US2005037005A15c8 AntigenUNIV COLUMBIA·Filed 2004·Application pending·0 cites
- 1461US2006110392A1Murine monoclonal antibody (5c8) recognizes T-B cell activating molecule (T-BAM) (CD40 LIGAND) on the surface of T-lymphocytes, compositions containing same and methods of useUNIV COLUMBIA·Filed 2004·Application pending·0 cites
- 1558US2005118166A1Therapeutic applications for the anti-T-BAM (CD40-1) monoclonal antibody 5C8BIOGEN INC·Filed 2003·Application pending·0 cites
- 1657US7070777B1Method for inhibiting inflammation with an antibody that binds the 5C8 proteinUNIV COLUMBIA·Filed 1995·Granted Jul 4, 2006·15 cites·10 claims
- 1754US2008050369A1Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cellsYELLIN MICHAEL J·Filed 2007·Application pending·0 cites
- 1851US2021077832A1Methods of treating cancer with dendritic cell mobilizing agentsCELLDEX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1948US2003219437A1Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cellsFiled 2002·Application pending·0 cites
- 2046US2006057626A1Assessment of CTLA-4 polymorphisms in CTLA-4 blockade therapyNICHOL GEOFFREY M·Filed 2005·Application pending·0 cites
- 2142US2009214544A1Method of treating cd30 positive lymphomasMEDAREX·Filed 2006·Application pending·0 cites
- 2229US2003099642A1Therapeutic applications for the anti-t-bam (cd40l) monoclonal antibody 5c8 in the treatment of vasculitisFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael J. Yellin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →